We Just Had An Epiphany
Tag: BetterHelp
Year-Old CEO Could Start Making an Impact: Can Teladoc (TDOC) Reboot Growth, Turn a Profit, and Send Its Stock Back to the Moon?
Teladoc Health is down 97% from ATH — but Citron says Livongo is booming, institutions are buying, and the CEO just hit his one-year mark. Bargain bin or value trap?
Teladoc: Still Waiting for Insiders and Hedge Funds to Swipe Right
TDOC is back in the spotlight with a 20% gain—but is the recovery real? From big losses to insider silence, Teladoc’s journey is part growth story, part therapy session. We break it down (with emojis and a side of humor).